Department of Reproductive Medicine and Gynaecology, University Medical Center Utrecht, Utrecht, The Netherlands.
BMC Womens Health. 2012 Aug 8;12:22. doi: 10.1186/1472-6874-12-22.
In in vitro fertilization (IVF) and intracytoplasmatic sperm injection (ICSI) treatment a large drop is present between embryo transfer and occurrence of pregnancy. The implantation rate per embryo transferred is only 30%. Studies have shown that minor intrauterine abnormalities can be found in 11-45% of infertile women with a normal transvaginal sonography or hysterosalpingography. Two randomised controlled trials have indicated that detection and treatment of these abnormalities by office hysteroscopy after two failed IVF cycles leads to a 9-13% increase in pregnancy rate. Therefore, screening of all infertile women for intracavitary pathology prior to the start of IVF/ICSI is increasingly advocated. In absence of a scientific basis for such a policy, this study will assess the effects and costs of screening for and treatment of unsuspected intrauterine abnormalities by routine office hysteroscopy, with or without saline infusion sonography (SIS), prior to a first IVF/ICSI cycle.
METHODS/DESIGN: Multicenter randomised controlled trial in asymptomatic subfertile women, indicated for a first IVF/ICSI treatment cycle, with normal findings at transvaginal sonography. Women with recurrent miscarriages, prior hysteroscopy treatment and intermenstrual blood loss will not be included. Participants will be randomised for a routine fertility work-up with additional (SIS and) hysteroscopy with on-the-spot-treatment of predefined intrauterine abnormalities versus the regular fertility work-up without additional diagnostic tests. The primary study outcome is the cumulative ongoing pregnancy rate resulting in live birth achieved within 18 months of IVF/ICSI treatment after randomisation. Secondary study outcome parameters are the cumulative implantation rate; cumulative miscarriage rate; patient preference and patient tolerance of a SIS and hysteroscopy procedure. All data will be analysed according to the intention-to-treat principle, using univariate and multivariate logistic regression and cox regression. Cost-effectiveness analysis will be performed to evaluate the costs of the additional tests as routine procedure. In total 700 patients will be included in this study.
The results of this study will help to clarify the significance of hysteroscopy prior to IVF treatment.
NCT01242852.
在体外受精(IVF)和卵胞浆内单精子注射(ICSI)治疗中,胚胎移植和妊娠发生之间存在很大的差距。每个胚胎移植的着床率仅为 30%。研究表明,在经阴道超声或子宫输卵管造影正常的不孕女性中,11-45%可发现轻微的子宫内异常。两项随机对照试验表明,在两次 IVF 失败后通过办公室宫腔镜检查发现并治疗这些异常,可使妊娠率提高 9-13%。因此,越来越提倡在开始 IVF/ICSI 之前对所有不孕女性进行宫腔内病理筛查。由于缺乏这种政策的科学依据,本研究将评估在首次 IVF/ICSI 周期前,通过常规办公室宫腔镜检查,以及是否联合盐水灌注超声(SIS),对未察觉的子宫内异常进行筛查和治疗的效果和成本。
方法/设计:多中心随机对照试验,纳入有正常经阴道超声表现的无症状性生育力低下女性,计划进行首次 IVF/ICSI 治疗周期。反复流产、既往宫腔镜治疗和经间出血的女性将不被纳入。参与者将被随机分配进行常规生育检查,或在常规生育检查的基础上进行额外的(SIS 和)宫腔镜检查,并对预定的子宫内异常进行现场治疗。主要研究结果是在随机分组后 18 个月内通过 IVF/ICSI 治疗获得的活产累积持续妊娠率。次要研究结果参数是累积着床率、累积流产率、患者对 SIS 和宫腔镜检查的偏好和耐受性。所有数据将根据意向治疗原则进行分析,采用单变量和多变量逻辑回归和 Cox 回归。将进行成本效益分析,以评估作为常规程序的额外检查的成本。本研究共纳入 700 例患者。
本研究的结果将有助于阐明 IVF 治疗前宫腔镜检查的意义。
NCT01242852。